Treeline, an innovative software platform developed by Sails Company (YCW15), has successfully raised an impressive $421 million in its latest funding round. This significant injection of capital will enable Treeline to further solidify its mission of democratizing software development by providing a higher-level abstraction that simplifies the coding process for users. With only 0.2% of the global population proficient in coding, Treeline IDE offers a revolutionary solution that allows product owners to navigate the complexities of software development without deep programming knowledge. By utilizing declarative trees rather than traditional imperative coding, Treeline eliminates runtime bugs, optimizes database queries automatically, and generates pristine API documentation, all of which streamline development workflows and reduce budget expenditures. This funding will drive enhancements to the platform, expanding its capabilities and making it even more accessible to businesses seeking efficient, secure, and hassle-free software solutions. As Treeline apps are built on the widely adopted Sails.js framework, they benefit from a robust foundation that has gained traction among hundreds of thousands of developers worldwide. With this new level of financial backing, Treeline is poised to revolutionize the software industry, empowering a broader audience to create and manage applications effortlessly. As the company positions itself at the forefront of the no-code movement, this funding is not just a milestone for Treeline—it represents a pivotal moment for the future of software development.
Treeline Secures $42.1 Million in Funding - Revolutionizing Software Development with Higher-Level Abstraction
Get the full Treeline company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Webclew
Webclew helps digital domain owners regain control over data collection and compliance. - Discover tracking without valid consent. - Keep policies up-to-date. - Ensure vendors comply with data processing agreements. Our SaaS solution monitors your domains & apps to turn a flurry of web requests into a comprehensive view on online data collection and compliance threats. We provide a fully automated process so our customers can focus on resolving actionable alerts.
$1.9M Seed
today
Capital B
Capital B is a nonprofit local/national news organization for Black audiences. Cofounded by veteran news leaders Lauren Williams and Akoto Ofori-Atta, Capital B deliver quality, trustworthy, original reporting to Black people across the country.
$17.8M Unknown
today
Prisma Labs, Inc.
Prisma Labs is a mobile technology company specialising in deep learning-related products. Our goal is to move forward mobile photography and video creation to the next level using neural networks, deep learning and computer vision technics. We aim to create new ways for people to express their emotions through the camera.
$100.0K Unknown
today
Atro
Atro is a venture-backed cybersecurity platform for SMBs, MSPs, and insurance providers that makes protecting sensitive data an entirely stress-free experience. Built by a team of world-class experts who understand the struggles of starting small, Atro is dedicated to solving cyber disparities with solutions that are accessible to every business owner. Want to see Atro in action? Watch our product demos here: https://www.youtube.com/@Atro-Cybersecurity/playlists
$100.0K Unknown
today
3D Bio-Tissues ltd - powered by BSF plc
3D Bio-tissues (3DBT) is a biotechnology company redefining the efficiency of cell-based therapies and cellular agriculture. We specialize in the development of macromolecular crowders—simple, powerful media additives designed to mimic the natural physiological environment, accelerating growth and significantly reducing operational costs. At the core of our innovation is a commitment to making complex biology scalable. By optimizing the way cells interact with their environment, we help our partners move from lab-scale success to industrial-scale reality. Our Core Solutions: CityMix™ | Transforming Cultivated Meat: The biggest barrier to cultivated meat is the cost of media. CityMix™ is a patented macromolecular crowder that reduces the requirement for expensive growth factors and supplements. It enables higher yields and faster production times, making sustainable, slaughter-free meat commercially viable. CytoBoost™ | Powering Biopharmaceutical Science: Precision matters in bioprocessing. CytoBoost™ enhances the performance of cell lines used in drug discovery and therapeutic production. It stabilizes proteins and improves cellular productivity without complex media reformulations. CytoBoost™ REVIVE | The Post-Thaw Cell Enabler: Cryopreservation is a critical stressor for cells. CytoBoost™ REVIVE is specifically formulated to act as a post-thaw enabler, minimizing the "lag phase" and maximizing cell viability and recovery. It ensures that your research or production starts with the strongest biological foundation possible. Why 3DBT? We don’t just provide additives; we provide the tools for the next generation of life sciences. Whether you are aiming to lower the price of a cultivated steak or increase the yield of a life-saving biologic, our macromolecular crowding technology is the "plug-and-play" solution your bioprocess needs.
$100.0K Unknown
today